Intellijoint Surgical has received market authorization from the Japanese Pharmaceutical and Medical Device Agency (PMDA) for Intellijoint HIP® and will begin distribution in Japan through a well-established partner in that market . Intellijoint HIP is an easy-to-use, surgeon-controlled navigation system that provides real-time measurements to optimize implant alignment and positioning during hip replacement surgery.
“Gaining entry into the largest computer-assisted surgical navigation market is a major milestone for our team” says Armen Bakirtzian, Co-founder and CEO at Intellijoint. “We are marching forward on our mission to improve patients’ lives by providing every surgeon with effective, easy-to-use technology.”
Intellijoint HIP is already available in the United States, Canada and Australia and earlier this year had surpassed use in 20,000 hip surgeries since its launch in 2016 . The first cases in Japan are expected in May.
Intellijoint Surgical was featured on the Deloitte Technology Fast 50™ Companies list for two consecutive years, ranking 1st (2020) and 2nd (2019). We are excited to continue that rapid growth by entering the world’s largest computer-assisted surgical navigation market in the world.
Source: Intellijoint Surgical